Jazz Pharmaceuticals says it has finished buying Actio Biosciences.

Sep 15, 2026, 10:10 AM ETDealRead the original at sec.gov

Neutral

Jazz announced completion of the Actio acquisition and that Actio is now a wholly-owned subsidiary. The filing includes no price, revenue, or product details, so it does not change how we read Jazz.

JAZZ · Jazz Pharmaceuticals plc

AI read · Neutral

The AI's read

Jazz Pharmaceuticals said it completed the acquisition of Actio and made Actio a wholly-owned subsidiary, per a Form 8-K. The filing provides no purchase price, product details, or financial statements in the text provided, so the announcement is neutral for Jazz.

Get alerts for JAZZ

Follow Jazz Pharmaceuticals plc (JAZZ) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for JAZZ

Free on the App Store and Google Play, or on the web.